- ... sup>®</sup><inf>II</inf> manufactured using human serum albumin (HSA) exhibit similar safety and immunogenicity profiles when administered as a 2- ...
- ... primary aim of bone loss prevention and measured serum creatinine as a safety outcome. 231 No significant differences in serum creatinine were found between the calcium, vitamin D ...
- ... For persons on (stable dose of) burosumab for safety & efficacy monitoring Serum phosphate, calcium, & creatinine, ALP, intact PTH Note: The ... Weber TJ, Liu S, Indridason OS, Quarles LD. Serum FGF23 levels in normal and disordered ... San Martin J, Imel EA. Efficacy and safety of burosumab in children aged 1-4 years ...
- ... Noda M, et al. [Minimal effective dose on serum cholesterol concentration and the safety evaluation of dressing containing plant sterol in Japanese ...
- ... Noda M, et al. [Minimal effective dose on serum cholesterol concentration and the safety evaluation of dressing containing plant sterol in Japanese ...
- ... ill, triglycerides should be monitored to ensure the safety of the baby. Serum or plasma phosphate ( recommendations 1.7.9 and ...
- ... tenofovir could result in increased effectiveness and lower serum levels could result in increased safety, including reduction in known negative effects of tenofovir ...
- ... of exacerbations of chronic obstructive pulmonary disease: Efficacy, safety, and effects on the serum levels of soluble differentiation molecules]. Terapevticheskii Arkhiv. 2016; ...
- ... ongoing prospective clinical trial ( NCT05509595 ) to evaluate the safety and efficacy of burosumab to normalize serum phosphate levels in individuals with FD and FGF23- ...
- ... H, et al. Relationship between coronary events and serum cholesterol during 10 years of low-dose simvastatin therapy: long-term efficacy and safety in Japanese patients with hypercholesterolemia in the Japan ...
597 results